BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Padmanabhan P, Desikan R, Dixit NM. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. PLoS Comput Biol 2020;16:e1008461. [PMID: 33290397 DOI: 10.1371/journal.pcbi.1008461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Marín-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, Flórez-Álvarez L, Yepes LM, Rugeles MT, Zapata-Builes W, Hernandez JC, Taborda NA. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms. Molecules 2021;26:6900. [PMID: 34833991 DOI: 10.3390/molecules26226900] [Reference Citation Analysis]
2 Torices S, Cabrera R, Stangis M, Naranjo O, Fattakhov N, Teglas T, Adesse D, Toborek M. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection. J Neuroinflammation 2021;18:167. [PMID: 34325716 DOI: 10.1186/s12974-021-02210-2] [Reference Citation Analysis]
3 Kato Y, Nishiyama K, Nishimura A, Noda T, Okabe K, Kusakabe T, Kanda Y, Nishida M. Drug repurposing for the treatment of COVID-19. Journal of Pharmacological Sciences 2022. [DOI: 10.1016/j.jphs.2022.04.007] [Reference Citation Analysis]
4 Mule S, Singh A, Greish K, Sahebkar A, Kesharwani P, Shukla R. Drug repurposing strategies and key challenges for COVID-19 management. J Drug Target 2021;:1-17. [PMID: 34854327 DOI: 10.1080/1061186X.2021.2013852] [Reference Citation Analysis]
5 Wan X, Wu X, Wang D, Tan X, Liu X, Fu Z, Jiang H, Zheng M, Li X. An inductive graph neural network model for compound-protein interaction prediction based on a homogeneous graph. Brief Bioinform 2022:bbac073. [PMID: 35275993 DOI: 10.1093/bib/bbac073] [Reference Citation Analysis]
6 Ekanger CT, Zhou F, Bohan D, Lotsberg ML, Ramnefjell M, Hoareau L, Røsland GV, Lu N, Aanerud M, Gärtner F, Salminen PR, Bentsen M, Halvorsen T, Ræder H, Akslen LA, Langeland N, Cox R, Maury W, Stuhr LEB, Lorens JB, Engelsen AST. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus. Front Cell Infect Microbiol 2022;12:841447. [DOI: 10.3389/fcimb.2022.841447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hu S, Buser E, Arredondo J, Relyea D, Santos Rocha C, Dandekar S. Altered Expression of ACE2 and Co-receptors of SARS-CoV-2 in the Gut Mucosa of the SIV Model of HIV/AIDS. Front Microbiol 2022;13:879152. [PMID: 35495669 DOI: 10.3389/fmicb.2022.879152] [Reference Citation Analysis]
8 Feng F, Chen J, Zhao J, Li Y, Li M, Sun C. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection. Viruses 2021;13:2243. [PMID: 34835049 DOI: 10.3390/v13112243] [Reference Citation Analysis]
9 An Y, Wang X, Wu X, Chen L, Yang Y, Lin X, Wang N, Duan J, Long S, Zhao X. Oncolytic reovirus induces ovarian cancer cell apoptosis in a TLR3-dependent manner. Virus Res 2021;301:198440. [PMID: 33940002 DOI: 10.1016/j.virusres.2021.198440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Jung HE, Lee HK. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection. Viruses 2021;13:2132. [PMID: 34834939 DOI: 10.3390/v13112132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mateus D, Sebastião AI, Carrascal MA, Carmo AD, Matos AM, Cruz MT. Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection. Rev Med Virol 2021;:e2290. [PMID: 34534372 DOI: 10.1002/rmv.2290] [Reference Citation Analysis]
12 Ayele AG, Enyew EF, Kifle ZD. Roles of existing drug and drug targets for COVID-19 management. Metabol Open 2021;11:100103. [PMID: 34222852 DOI: 10.1016/j.metop.2021.100103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ni J, Lan F, Xu Y, Nakanishi H, Li X. Extralysosomal cathepsin B in central nervous system: Mechanisms and therapeutic implications. Brain Pathol 2022;:e13071. [PMID: 35411983 DOI: 10.1111/bpa.13071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kreutzberger AJB, Sanyal A, Ojha R, Pyle JD, Vapalahti O, Balistreri G, Kirchhausen T. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. J Virol 2021;95:e0097521. [PMID: 34406858 DOI: 10.1128/JVI.00975-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 [DOI: 10.1101/2020.12.18.423106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Konwar C, Asiimwe R, Inkster AM, Merrill SM, Negri GL, Aristizabal MJ, Rider CF, MacIsaac JL, Carlsten C, Kobor MS. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression. Epigenetics Chromatin 2021;14:54. [PMID: 34895312 DOI: 10.1186/s13072-021-00428-1] [Reference Citation Analysis]
17 Louis TJ, Qasem A, Abdelli LS, Naser SA. Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review. Microorganisms 2022;10:153. [PMID: 35056603 DOI: 10.3390/microorganisms10010153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Torices S, Cabrera R, Stangis M, Naranjo O, Adesse D, Toborek M. Expression of SARS-CoV-2-related Receptors in Cells of the Neurovascular Unit: Implications for HIV-1 Infection. Res Sq 2021:rs. [PMID: 33655239 DOI: 10.21203/rs.3.rs-228960/v1] [Reference Citation Analysis]
19 Abbasi AZ, Kiyani DA, Hamid SM, Saalim M, Fahim A, Jalal N. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2. J Med Virol 2021;93:4205-18. [PMID: 33638460 DOI: 10.1002/jmv.26911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Najmeddin A, Shapourabadi MB, Behdani M, Dorkoosh F. Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view. Biochim Biophys Acta Gen Subj 2021;:129974. [PMID: 34343644 DOI: 10.1016/j.bbagen.2021.129974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Saik OV, Klimontov VV. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity? IJMS 2022;23:7247. [DOI: 10.3390/ijms23137247] [Reference Citation Analysis]
22 Lin J, Tien C, Kuo Y, Lin E, Tsai W, Chen M, Tsai P, Su Y, Pathak N, Yang J, Yu C, Chuang Z, Wu H, Tsai W, Dai S, Liao H, Chai KM, Su Y, Chuang T, Liu S, Chen H, Dou H, Chen F, Chen C, Liao C, Yu G. Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection. Front Immunol 2022;13:872047. [DOI: 10.3389/fimmu.2022.872047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells 2021;10:796. [PMID: 33918318 DOI: 10.3390/cells10040796] [Reference Citation Analysis]
24 Maurin C, He Z, Mentek M, Verhoeven P, Pillet S, Bourlet T, Rogues F, Pugniet JL, Peyragrosse T, Barallon M, Perrache C, Aouimeur I, Acquart S, Ninotta S, Baud'huin M, Vabres B, Poinard S, Gain P, Thuret G. Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study. PLoS Med 2022;19:e1003922. [PMID: 35231027 DOI: 10.1371/journal.pmed.1003922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ding X, Ye N, Qiu M, Guo H, Li J, Zhou X, Yang M, Xi J, Liang Y, Gong Y, Li J. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma. Chem Biol Interact 2022;353:109796. [PMID: 35007526 DOI: 10.1016/j.cbi.2022.109796] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sfera A, Thomas KG, Andronescu CV, Jafri N, Sfera DO, Sasannia S, Zapata-martín del Campo CM, Maldonado JC. Bromodomains in Human-Immunodeficiency Virus-Associated Neurocognitive Disorders: A Model of Ferroptosis-Induced Neurodegeneration. Front Neurosci 2022;16:904816. [DOI: 10.3389/fnins.2022.904816] [Reference Citation Analysis]
27 Padmanabhan P, Desikan R, Dixit NM. Modeling how antibody responses may determine the efficacy of COVID-19 vaccines. Nat Comput Sci 2022;2:123-31. [DOI: 10.1038/s43588-022-00198-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
28 Canedo-Marroquín G, Saavedra F, Andrade CA, Berrios RV, Rodríguez-Guilarte L, Opazo MC, Riedel CA, Kalergis AM. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments. Front Immunol 2020;11:569760. [PMID: 33362758 DOI: 10.3389/fimmu.2020.569760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Gao J, Mei H, Sun J, Li H, Huang Y, Tang Y, Duan L, Liu D, Pang Y, Wang Q, Gao Y, Song K, Zhao J, Zhang C, Liu J. Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation. Adv Biol (Weinh) 2022;:e2200007. [PMID: 35195371 DOI: 10.1002/adbi.202200007] [Reference Citation Analysis]
30 Kreutzberger AJB, Sanyal A, Ojha R, Pyle JD, Vapalahti O, Balistreri G, Kirchhausen T. Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease. bioRxiv 2021:2021. [PMID: 34100014 DOI: 10.1101/2021.06.01.446623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Prasad K, Ahamad S, Kanipakam H, Gupta D, Kumar V. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine. ACS Chem Neurosci 2021;12:930-44. [PMID: 33606519 DOI: 10.1021/acschemneuro.1c00019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
32 Mao B, Le-Trilling VTK, Wang K, Mennerich D, Hu J, Zhao Z, Zheng J, Deng Y, Katschinski B, Xu S, Zhang G, Cai X, Hu Y, Wang J, Lu M, Huang A, Tang N, Trilling M, Lin Y. Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro. Emerg Microbes Infect 2022;:1-29. [PMID: 34989664 DOI: 10.1080/22221751.2022.2026739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Mohanty SS, Sahoo CR, Padhy RN. Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19. AAPS PharmSciTech 2021;22:214. [PMID: 34378108 DOI: 10.1208/s12249-021-02089-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Sharma T, Hassan Baig M, Imran Khan M, Alotaibi SS, Alorabi M, Dong J. Computational screening of camostat and related compounds against human TMPRSS2: A Potential Treatment of COVID-19. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Garg AK, Mittal S, Padmanabhan P, Desikan R, Dixit NM. Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost. Front Immunol 2021;12:776933. [PMID: 34917089 DOI: 10.3389/fimmu.2021.776933] [Reference Citation Analysis]
36 Kim KS, Iwanami S, Oda T, Fujita Y, Kuba K, Miyazaki T, Ejima K, Iwami S. Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection. Life Sci Alliance 2021;4:e202101049. [PMID: 34344719 DOI: 10.26508/lsa.202101049] [Reference Citation Analysis]
37 Dessie G, Malik T. Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options. Infect Drug Resist 2021;14:1883-92. [PMID: 34079299 DOI: 10.2147/IDR.S308176] [Reference Citation Analysis]
38 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]